Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Current Assets (2016 - 2025)

Wave Life Sciences (WVE) has disclosed Current Assets for 11 consecutive years, with $614.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Assets rose 91.89% year-over-year to $614.8 million, compared with a TTM value of $614.8 million through Dec 2025, up 91.89%, and an annual FY2025 reading of $614.8 million, up 91.89% over the prior year.
  • Current Assets was $614.8 million for Q4 2025 at Wave Life Sciences, up from $215.5 million in the prior quarter.
  • Across five years, Current Assets topped out at $614.8 million in Q4 2025 and bottomed at $98.5 million in Q4 2022.
  • Average Current Assets over 5 years is $215.6 million, with a median of $189.6 million recorded in 2021.
  • The sharpest move saw Current Assets crashed 39.39% in 2022, then soared 138.87% in 2023.
  • Year by year, Current Assets stood at $162.6 million in 2021, then tumbled by 39.39% to $98.5 million in 2022, then skyrocketed by 138.87% to $235.4 million in 2023, then skyrocketed by 36.12% to $320.4 million in 2024, then surged by 91.89% to $614.8 million in 2025.
  • Business Quant data shows Current Assets for WVE at $614.8 million in Q4 2025, $215.5 million in Q3 2025, and $223.6 million in Q2 2025.